Sal Daher, CFA

Combining existing drugs with the targeting of biological features of ovarian tumours could extend life when platinum chemotherapy fails.

A self-controlled case series using individual-patient-level data from over 38 million people aged 16 years and over, reveals an increased risk of myocarditis within a week of receiving a first dose…

Senior Clinical Research Manager – Pediatric Experimental Therapeutics and Cancer Cellular Therapy Dana-Farber Cancer Institute Boston, MA Full time (Remote: 2-3 days remote/week) The Clinical…

Knowing you have a genetic mutation that puts you at risk of ovarian cancer can be life-saving. But with complex decisions awaiting anyone who has a disease variant, many people are choosing not to be…

A high-profile replication study in cancer biology has obtained disappointing results. Scientists must redouble their efforts to find out why.

Recent advances in bacterial whole-genome sequencing have resulted in a comprehensive catalog of ant

Germany Rations Covid Vaccine Doses Amid BioNTech Shortage

Nature Reviews Clinical Oncology – Helicobacter…

When asked about abstracts he thinks have the greatest potential to impact the standard of care in myeloma, Rafael Fonseca, MD, looked to emerging cellular therapies, specifically ciltacabtagene…

Iacta Pharmaceuticals and Tallc will enter into a strategic collaboration and licensing agreement to implement Tallc’s SmartCelle technology in clinical development, according to a press release from…